Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305

European Journal of Cancer(2023)10.1016/j.ejca.2023.113509Source: DataRank Database

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305 is a research paper published in European Journal of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.24)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Yael Flamand ORCID,P. Savvides ORCID,Jennifer M. Johnson ORCID,Ioannis Vathiotis ORCID,Marshall Levine

Live enrichment

PubMed:38215573 PMC:PMC11376484 OpenAlex:https://openalex.org/W4390415240

National Institutes of Health

Grant: U10CA180794

National Institutes of Health

Grant: U10CA180820

National Institutes of Health

Grant: UG1CA232760

National Institutes of Health

Grant: UG1CA233196

National Institutes of Health

Grant: UG1CA233337

National Institutes of Health

Grant: UG1CA233341

National Cancer Institute

ECOG-ACRIN Cancer Research Group

FWCI

0.24

Citation Percentile

0.6%

Citation Trend

2025

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11376484/pdf/nihms-2014890.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0959804923008110?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804923008110?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11376484

Fields of Study

Head and Neck Cancer StudiesEsophageal Cancer Research and TreatmentBrain Metastases and TreatmentHumansPrognosisSquamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalHead and Neck NeoplasmsRisk FactorsAntineoplastic Combined Chemotherapy ProtocolsRetrospective Studies

MeSH Terms

Squamous Cell Carcinoma of Head and NeckAntineoplastic Combined Chemotherapy ProtocolsHead and Neck NeoplasmsHumansNeoplasm Recurrence, LocalPrognosisRetrospective StudiesRisk Factors

Keywords

MedicineInternal medicineOncologyHead and neck cancerHazard ratioBevacizumabUnivariate analysisHead and neck squamous-cell carcinomaChemotherapyMultivariate analysisConfidence intervalCohortRadiation therapyCancerPrognosisHnscc

Sustainable Development Goals

SDG 0: Good health and well-being